These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 26605925)

  • 21. Opiophobia and opiophilia: the war continues.
    Oliveira Júnior JO
    Rev Assoc Med Bras (1992); 2018 May; 64(5):393-396. PubMed ID: 30304135
    [No Abstract]   [Full Text] [Related]  

  • 22. The prevalence and trend of drug addiction in the United States and factors influencing it. 1924.
    Kolb L; Du Mez AG
    Public Health Rep; 2006; 121 Suppl 1():161-73; discussion 160. PubMed ID: 16550777
    [No Abstract]   [Full Text] [Related]  

  • 23. History of drug use and drug control.
    Fox DM
    Mt Sinai J Med; 1991 Oct; 58(5):403-5; discussion 437-42. PubMed ID: 1753976
    [No Abstract]   [Full Text] [Related]  

  • 24. Health Policy Watch: One State's Legislation to Prevent Opioid Deaths.
    Rundio A
    J Addict Nurs; 2016; 27(1):51-2. PubMed ID: 26950843
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug wars: policy hots and historical cools.
    Courtwright DT
    Bull Hist Med; 2004; 78(2):440-50. PubMed ID: 15305424
    [No Abstract]   [Full Text] [Related]  

  • 26. The National Imperative to Align Practice and Policy with the Actual CDC Opioid Guideline.
    Darnall BD
    Pain Med; 2020 Feb; 21(2):229-231. PubMed ID: 31334761
    [No Abstract]   [Full Text] [Related]  

  • 27. Professional casualties in America's war on drugs.
    Brushwood DB
    Am J Health Syst Pharm; 2003 Oct; 60(19):2004-6. PubMed ID: 14531249
    [No Abstract]   [Full Text] [Related]  

  • 28. The Garden State just got greener: New Jersey is the fourteenth state in the nation to legalize medical marijuana.
    Brown M
    Seton Hall Law Rev; 2011; 41(4):1519-67. PubMed ID: 22368811
    [No Abstract]   [Full Text] [Related]  

  • 29. CDC: Major disparities in opioid prescribing among states: some states crack down on excess prescribing.
    Kuehn BM
    JAMA; 2014 Aug; 312(7):684-6. PubMed ID: 25099564
    [No Abstract]   [Full Text] [Related]  

  • 30. Tribute to Peter Lee, pioneer of methadone treatment in Hong Kong.
    Lee SS; Newman R
    Int J Drug Policy; 2009 Mar; 20(2):99-100. PubMed ID: 19150237
    [No Abstract]   [Full Text] [Related]  

  • 31. "The judgment is reversed".
    Northup GW
    J Am Osteopath Assoc; 2001 Jun; 101(6):359-60. PubMed ID: 11436874
    [No Abstract]   [Full Text] [Related]  

  • 32. A brief history of methadone in the treatment of opioid dependence: a personal perspective.
    Payte JT
    J Psychoactive Drugs; 1991; 23(2):103-7. PubMed ID: 1765883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs with abuse potential: a 70-year history of increasing government control.
    Grapes ZT; Brown TR
    Hosp Formul; 1976 Nov; 11(11):608, 611-3. PubMed ID: 800780
    [No Abstract]   [Full Text] [Related]  

  • 34. Legal and social aspects of drug abuse in historical perspective. Is the drug abuser a patient or a criminal?
    Muuss RE
    Adolescence; 1974; 9(36):495-506. PubMed ID: 4617499
    [No Abstract]   [Full Text] [Related]  

  • 35. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 36. International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering.
    Darnall BD; Juurlink D; Kerns RD; Mackey S; Van Dorsten B; Humphreys K; Gonzalez-Sotomayor JA; Furlan A; Gordon AJ; Gordon DB; Hoffman DE; Katz J; Kertesz SG; Satel S; Lawhern RA; Nicholson KM; Polomano RC; Williamson OD; McAnally H; Kao MC; Schug S; Twillman R; Lewis TA; Stieg RL; Lorig K; Mallick-Searle T; West RW; Gray S; Ariens SR; Sharpe Potter J; Cowan P; Kollas CD; Laird D; Ingle B; Julian Grove J; Wilson M; Lockman K; Hodson F; Palackdharry CS; Fillingim RB; Fudin J; Barnhouse J; Manhapra A; Henson SR; Singer B; Ljosenvoor M; Griffith M; Doctor JN; Hardin K; London C; Mankowski J; Anderson A; Ellsworth L; Davis Budzinski L; Brandt B; Hartley G; Nickels Heck D; Zobrosky MJ; Cheek C; Wilson M; Laux CE; Datz G; Dunaway J; Schonfeld E; Cady M; LeDantec-Boswell T; Craigie M; Sturgeon J; Flood P; Giummarra M; Whelan J; Thorn BE; Martin RL; Schatman ME; Gregory MD; Kirz J; Robinson P; Marx JG; Stewart JR; Keck PS; Hadland SE; Murphy JL; Lumley MA; Brown KS; Leong MS; Fillman M; Broatch JW; Perez A; Watford K; Kruska K; Sophia You D; Ogbeide S; Kukucka A; Lawson S; Ray JB; Wade Martin T; Lakehomer JB; Burke A; Cohen RI; Grinspoon P; Rubenstein MS; Sutherland S; Walters K; Lovejoy T
    Pain Med; 2019 Mar; 20(3):429-433. PubMed ID: 30496540
    [No Abstract]   [Full Text] [Related]  

  • 37. Shattuck lecture. Innovation, regulation, and the FDA.
    Hamburg MA
    N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835
    [No Abstract]   [Full Text] [Related]  

  • 38. THE OPI0ID ABUSE EPIDEMIC. PROTECT YOURSELF FROM LIABILITY.
    Brunken JD
    Med Econ; 2015 Aug; 92(16):57. PubMed ID: 26540790
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Huyghe B
    Bull Cercle Benelux Hist Pharm; 1994 Oct; (87):29-41. PubMed ID: 11640779
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
    Costa E Silva JA
    Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.